Get all your news in one place.
100's of premium titles.
One app.
Start reading
Evening Standard
Evening Standard
Health
Ella Pickover

Alzheimer’s drug rejected for widespread use by NHS spending watchdog

A new drug to treat the cause of Alzheimer’s has been rejected for widespread NHS use (PA) - (PA Wire)

A new Alzheimer’s drug has been rejected for widespread use in the health service in England after the health spending watchdog said it “does not currently demonstrate value for the NHS”.

The news comes as the UK’s medicines regulator said donanemab could be licensed for use in the UK.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.